Literature DB >> 20362006

Development of a multiplex real-time RT-PCR assay for detection of influenza A, influenza B, RSV and typing of the 2009-H1N1 influenza virus.

Weston C Hymas1, Alan Mills, Sheri Ferguson, Janine Langer, Rosemary C She, Walt Mahoney, David R Hillyard.   

Abstract

A high-throughput real-time RT-PCR assay was developed to amplify and detect a conserved region of the hemagglutinin gene of the 2009-H1N1 influenza A virus using a minor groove binder-conjugated hybridization probe. The assay was paired with a separate triplex real-time assay that detects influenza A via the matrix gene, influenza B and RSV in a multiplex format and compared with the Centers for Disease Control and Prevention (CDC) rRT-PCR assay using 143 samples. The 2009-H1N1 portion of the multiplex assay had 100% correlation with the CDC assay, while the triplex assay had a 99% agreement. An additional 105 samples collected from October to November 2009 were also tested using both the individual 2009-H1N1 and triplex assays. Of these 105 samples, eight were positive for the hemagglutinin target in the H1N1 assay and negative for the matrix target in the triplex assay. Discrepant analysis revealed single nucleotide polymorphisms within the matrix gene of 2009-H1N1 virus-positive samples. The limit of detection for the 2009-H1N1 assay was between 750 and 1,500 copies/reaction and no cross-reactivity with other respiratory pathogens was observed. Overall, this multiplexed format proved to be sensitive, robust and easy to use and serves as a useful tool for pandemic testing. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362006     DOI: 10.1016/j.jviromet.2010.03.020

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Unbiased Detection of Respiratory Viruses by Use of RNA Sequencing-Based Metagenomics: a Systematic Comparison to a Commercial PCR Panel.

Authors:  Erin H Graf; Keith E Simmon; Keith D Tardif; Weston Hymas; Steven Flygare; Karen Eilbeck; Mark Yandell; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

2.  Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Erik Iverson; Gabriel Defang; Patrick J Blair; Lynn E Eberly; Jason Maguire; Anuradha Ganesan; Dennis Faix; Christopher Duplessis; Tahaniyat Lalani; Timothy Whitman; Carolyn Brandt; Grace Macalino; Eugene V Millar; Timothy Burgess
Journal:  Vaccine       Date:  2011-03-01       Impact factor: 3.641

Review 3.  Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic.

Authors:  Swati Kumar; Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Pilot Evaluation of RT-PCR/Electrospray Ionization Mass Spectrometry (PLEX-ID/Flu assay) on Influenza-Positive Specimens.

Authors:  Samuel Cordey; Yves Thomas; Patricia Suter; Laurent Kaiser
Journal:  Open Virol J       Date:  2012-05-09

5.  GeXP analyzer-based multiplex reverse-transcription PCR assay for the simultaneous detection and differentiation of eleven duck viruses.

Authors:  Yan-Fang Zhang; Zhi-Xun Xie; Li-Ji Xie; Xian-Wen Deng; Zhi-Qin Xie; Si-Si Luo; Li Huang; Jiao-Ling Huang; Ting-Ting Zeng
Journal:  BMC Microbiol       Date:  2015-10-30       Impact factor: 3.605

6.  Rapid detection of the pandemic 2009 H1N1 virus M gene by real-time and gel-based RT-PCR assays.

Authors:  Wenjun Ma; Richard Oberst; Xi Li; Deborah Clouser; Richard Hesse; Raymond Rowland; Juergen A Richt
Journal:  Influenza Other Respir Viruses       Date:  2010-10-08       Impact factor: 4.380

7.  A Tale of Tails: Dissecting the Enhancing Effect of Tailed Primers in Real-Time PCR.

Authors:  Frank Vandenbussche; Elisabeth Mathijs; David Lefebvre; Kris De Clercq; Steven Van Borm
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.